Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tycho Baumann

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2020
The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease OutcomeChristian Brieghel, Caspar da Cunha-Bang, Christina Westmose Yde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2020
Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based StudyAlfredo Rivas-Delgado, Ferran Nadeu, Anna Enjuanes, et al.
British Journal of Haematology|September 14, 2021
Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformationGabriela Bastidas-Mora, Sílvia Beà, Alba Navarro, et al.
Nature Communications|July 9, 2020
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasmsFerran Nadeu, Rut Mas-de-Les-Valls, Alba Navarro, et al.
Genes, Chromosomes & Cancer|August 26, 2015
Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemiaItziar Salaverria, David Martín-Garcia, Cristina López, et al.
Blood|February 4, 2016
Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemiaFerran Nadeu, Julio Delgado, Cristina Royo, et al.
Haematologica|March 11, 2021
Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patientsSilvia Ramos-Campoy, Anna Puiggros, Sílvia Beà, et al.
Frontiers in Immunology|June 13, 2020
Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical TrialMaria Castella, Miguel Caballero-Baños, Valentín Ortiz-Maldonado, et al.
Haematologica|September 29, 2018
Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemiaNeus Giménez, Alejandra Martínez-Trillos, Arnau Montraveta, et al.
Cancers|August 12, 2022
<i>TP53</i> Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex KaryotypeSilvia Ramos-Campoy, Anna Puiggros, Joanna Kamaso, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2020
The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease OutcomeChristian Brieghel, Caspar da Cunha-Bang, Christina Westmose Yde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2020
Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based StudyAlfredo Rivas-Delgado, Ferran Nadeu, Anna Enjuanes, et al.
British Journal of Haematology|September 14, 2021
Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformationGabriela Bastidas-Mora, Sílvia Beà, Alba Navarro, et al.
Nature Communications|July 9, 2020
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasmsFerran Nadeu, Rut Mas-de-Les-Valls, Alba Navarro, et al.
Genes, Chromosomes & Cancer|August 26, 2015
Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemiaItziar Salaverria, David Martín-Garcia, Cristina López, et al.
Blood|February 4, 2016
Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemiaFerran Nadeu, Julio Delgado, Cristina Royo, et al.
Haematologica|March 11, 2021
Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patientsSilvia Ramos-Campoy, Anna Puiggros, Sílvia Beà, et al.
Frontiers in Immunology|June 13, 2020
Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical TrialMaria Castella, Miguel Caballero-Baños, Valentín Ortiz-Maldonado, et al.
Haematologica|September 29, 2018
Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemiaNeus Giménez, Alejandra Martínez-Trillos, Arnau Montraveta, et al.
Cancers|August 12, 2022
<i>TP53</i> Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex KaryotypeSilvia Ramos-Campoy, Anna Puiggros, Joanna Kamaso, et al.
Pageof 6